Search Results - "Tedesco Silva, Hélio"

Refine Results
  1. 1

    Long-Term Follow-Up of a Phase III Clinical Trial Comparing Tacrolimus Extended-Release/MMF, Tacrolimus/MMF, and Cyclosporine/MMF in De Novo Kidney Transplant Recipients by Silva, Hélio Tedesco, Yang, Harold C, Meier-Kriesche, Herwig-Ulf, Croy, Richard, Holman, John, Fitzsimmons, William E, First, M Roy

    Published in Transplantation (27-03-2014)
    “…BACKGROUNDIn a phase III, open-label, comparative, noninferiority study, 638 subjects receiving de novo kidney transplants were randomized to one of three…”
    Get full text
    Journal Article
  2. 2

    Prolonged Delayed Graft Function Is Associated with Inferior Patient and Kidney Allograft Survivals by de Sandes-Freitas, Tainá Veras, Felipe, Cláudia Rosso, Aguiar, Wilson Ferreira, Cristelli, Marina Pontello, Tedesco-Silva, Hélio, Medina-Pestana, José Osmar

    Published in PloS one (17-12-2015)
    “…It is unclear if there is an association between the duration of delayed graft function (DGF) and kidney transplant (KT) outcomes. This study investigated the…”
    Get full text
    Journal Article
  3. 3

    Chronic kidney disease progression in kidney transplant recipients: A focus on traditional risk factors by Carminatti, Moisés, TedescoSilva, Hélio, Silva Fernandes, Natália Maria, Sanders‐Pinheiro, Helady

    Published in Nephrology (Carlton, Vic.) (01-02-2019)
    “…ABSTRACT Kidney transplant recipients are a subset of patients with chronic kidney disease (CKD) that remain at high risk for progression to dialysis and…”
    Get full text
    Journal Article
  4. 4

    Acute rejection in pediatric renal transplantation: Retrospective study of epidemiology, risk factors, and impact on renal function by Nascimento Ghizoni Pereira, Luiza, TedescoSilva, Hélio, Koch‐Nogueira, Paulo Cesar

    Published in Pediatric transplantation (01-03-2021)
    “…AR is a major relevant and challenging topic in pediatric kidney transplantation. Our objective was to evaluate cumulative incidence of AR in pediatric kidney…”
    Get full text
    Journal Article
  5. 5

    HLA‐A homozygosis is associated with susceptibility to COVID‐19 by De Marco, Renato, Faria, Tathyane C., Mine, Karina L., Cristelli, Marina, Medina‐Pestana, José O., TedescoSilva, Hélio, Gerbase‐DeLima, Maria

    Published in HLA (01-08-2021)
    “…The purpose of this single center retrospective study was to investigate the relationship between HLA and ABO polymorphisms and COVID‐19 susceptibility and…”
    Get full text
    Journal Article
  6. 6
  7. 7

    HLA‐DPB1 molecular mismatches are risk factors for acute rejection and low 5‐year graft function in first kidney transplants by Marco, Renato, Requião‐Moura, Lúcio R., Raimundo, Tamiris R. F., Mourão, Tuíla B., Rampim, Gisele F., Medina‐Pestana, José O., TedescoSilva, Hélio, Gerbase‐DeLima, Maria

    Published in HLA (01-03-2023)
    “…The study aimed to investigate the impact of HLA‐DPB1 allelic and molecular mismatches on the occurrence of acute rejection (AR) and low 5‐year graft function…”
    Get full text
    Journal Article
  8. 8

    High soluble HLA‐DQB2 levels in posttransplant serum are associated with kidney graft dysfunction by Mine, Karina L, Marco, Renato, Raimundo, Tamiris R.F., Ernesto, Julia V., Medina‐Pestana, José O., TedescoSilva, Hélio, Gerbase‐DeLima, Maria

    Published in International journal of immunogenetics (01-04-2022)
    “…HLA‐DQB2 is a gene of limited polymorphism, with unknown function that presents at least two transcript variants: v1, which encodes the full‐length beta‐chain,…”
    Get full text
    Journal Article
  9. 9

    Impact of Combinations of Donor and Recipient Ages and Other Factors on Kidney Graft Outcomes by Gerbase-DeLima, Maria, de Marco, Renato, Monteiro, Franscisco, Tedesco-Silva, Hélio, Medina-Pestana, José O, Mine, Karina L

    Published in Frontiers in immunology (22-05-2020)
    “…As the availability of kidneys for transplantation continues to be outpaced by its growing demand, there has been an increasing utilization of older deceased…”
    Get full text
    Journal Article
  10. 10

    Mortality predictors in renal transplant recipients with severe sepsis and septic shock by de Carvalho, Mônica Andrade, Freitas, Flávio Geraldo Rezende, Silva Junior, Hélio Tedesco, Bafi, Antônio Toneti, Machado, Flávia Ribeiro, Pestana, José Osmar Medina

    Published in PloS one (04-11-2014)
    “…The growing number of renal transplant recipients in a sustained immunosuppressive state is a factor that can contribute to increased incidence of sepsis…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Sex Differences among Overweight/Obese Kidney Transplant Recipients Requiring Oxygen Support Amid the COVID-19 Pandemic by Veronese-Araújo, Alexandre, de Lucena, Débora D, Aguiar-Brito, Isabella, Cristelli, Marina P, Tedesco-Silva, Hélio, Medina-Pestana, José O, Rangel, Érika B

    Published in Medicina (Kaunas, Lithuania) (27-08-2023)
    “…Background and Objectives: Overweight/obesity puts individuals at greater risk for COVID-19 progression and mortality. We aimed to evaluate the impact of…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Time-Dependent and Immunosuppressive Drug-Associated Adverse Event Profiles in De Novo Kidney Transplant Recipients Converted from Tacrolimus to Sirolimus Regimens by Felix, Maria Julia Pereira, Felipe, Claudia Rosso, Tedesco-Silva, Hélio, Osmar Medina-Pestana, José

    Published in Pharmacotherapy (01-02-2016)
    “…Study Objective To evaluate the safety and tolerability of immunosuppressive drugs used in a planned randomized conversion from a calcineurin inhibitor,…”
    Get full text
    Journal Article
  16. 16

    Impact of Dialysis Time on Long-term Outcomes in HLA-identical Living Donor Kidney Transplant Recipients by Ferreira, Evelyn S, Requião-Moura, Lucio, Nakamura, Mônica R, Foresto, Renato Demarchi, Medina Pestana, José, Tedesco-Silva, Hélio

    Published in Transplantation direct (01-09-2024)
    “…Dialysis vintage is associated with worse outcomes after kidney transplantation. The reasons behind this observation include immunological and nonimmunological…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    The Challenge of Achieving Target Drug Concentrations in Clinical Trials: Experience From the Symphony Study by EKBERG, Henrik, MAMELOK, Richard D, PEARSON, Thomas C, VINCENTI, Flavio, TEDESCO-SILVA, Hélio, DALOZE, Pierre

    Published in Transplantation (15-05-2009)
    “…The Symphony study compared four immunosuppressant regimens, defined by protocol-specified target drug concentrations. This subanalysis examines actual drug…”
    Get full text
    Journal Article
  20. 20

    Long-Term Follow-Up of De Novo Use of mTOR and Calcineurin Inhibitors After Kidney Transplantation by de Paula, Mayara Ivani, Medina Pestana, José Osmar, Nicolau Ferreira, Alexandra, Pontello Cristelli, Marina, Fabiano Franco, Marcello, Aguiar, Wilson Ferreira, Tedesco-Silva, Hélio, Rosso Felipe, Claudia

    Published in Therapeutic drug monitoring (01-02-2016)
    “…Long-term efficacy and safety of de novo use of the mammalian target of rapamycin inhibitors (mTORi) have been evaluated primarily using registry data. This…”
    Get full text
    Journal Article